Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1038133/000103813323000023/hska-20230331.htm
June 2023
June 2023
June 2023
June 2023
May 2023
May 2023
May 2023
April 2023
February 2023
February 2023
Heska Corporation | ![]() | ||||||||||
Jon Aagaard | |||||||||||
Investor Relations | |||||||||||
970.619.3033 | |||||||||||
investorrelations@heska.com |
Q1 ($) | Q1 (%) YOY | |||||||
Consolidated revenue | $62.4 | (3.7)% | ||||||
Q1 (%) | Q1 YOY bps1 | |||||||
Consolidated gross margin | 43.9% | (110) | ||||||
Net loss margin2 | (15.7)% | (90) | ||||||
Adjusted EBITDA margin3 | 5.2% | (670) | ||||||
Q1 ($) | Q1 (%) YOY | |||||||
Net loss attributable to Heska | $(10.1) | (1.4)% | ||||||
Net loss | $(9.8) | (1.8)% | ||||||
Adjusted EBITDA3 | $3.3 | (57.6)% | ||||||
EPS, Diluted | $(0.97) | —% | ||||||
Non-GAAP EPS, Diluted3 | $0.17 | (37.0)% |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1038133/000103813323000023/hska-20230331.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Heska Corp.
Heska Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:
Rating
Learn More![]()
Excluding the impact of the acquisition, gross profit and gross margin percentage favorability were driven by increased revenue as a result of higher consumables pricing and favorable idle plant and mix impacts within our OVP business.
Management uses EBITDA, adjusted EBITDA, adjusted EBITDA margin and non-GAAP net income per diluted share as key profitability measures, which are included in our quarterly analyses of our operating results to our senior management team, our annual budget and related goal setting and other performance measurements.
Gross margin percentage, excluding the impact of the acquisition, increased to 46.8%, driven by increased consumable sales as well as favorable idle plant impacts and product mix within our OVP business.
The decrease in tax benefit for the 2023 period versus the 2022 period is due to tax expense from transaction costs and employee stock compensation.
Such statements, which include statements concerning future revenue sources and concentration, international market expansion, gross margin, selling and marketing expenses, remaining minimum performance obligations, research and development expenses, general and administrative expenses, capital resources, financings or borrowings and additional losses, are subject to risks and uncertainties, including, but not limited to, those discussed under the caption "Risk Factors" contained in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2022 that could cause actual results to differ materially from those projected.
-42- Liquidity, Capital Resources and...Read more
For the three months ended...Read more
The decrease is primarily driven...Read more
(4) Represents income tax expense...Read more
The change for the three...Read more
The non-GAAP financial measures presented...Read more
-38- Net Loss Attributable to...Read more
Our portfolio includes Point of...Read more
The acquisition of LightDeck unfavorably...Read more
The decreases in both gross...Read more
Research and development expenses decreased...Read more
The Company recognized $0.6 million...Read more
Our belief may prove to...Read more
Inflation, Foreign Currency, Interest Rate...Read more
Since items in this area...Read more
North America Segment North America...Read more
This incorporates the discrete tax...Read more
Income Tax Benefit For the...Read more
In the three months ended...Read more
International Segment International segment revenue...Read more
Our experience has been that...Read more
General and administrative expenses increased...Read more
Gross margin percentage decreased to...Read more
See "Non-GAAP Financial Measures" for...Read more
Operating Expenses Selling and marketing...Read more
We believe these non-GAAP measures...Read more
The reduction in operating loss...Read more
The decrease in gross profit...Read more
We view this facility as...Read more
For example, we actively seek...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Heska Corp provided additional information to their SEC Filing as exhibits
Ticker: HSKA
CIK: 1038133
Form Type: 10-Q Quarterly Report
Accession Number: 0001038133-23-000023
Submitted to the SEC: Fri May 05 2023 12:50:39 PM EST
Accepted by the SEC: Fri May 05 2023
Period: Friday, March 31, 2023
Industry: Biological Products No Disgnostic Substances